SGX:RF1U

Stock Analysis Report

Executive Summary

RHT is the first business trust to be listed on the Main Board of the Singapore Exchange Limited ("SGX-ST") with India based healthcare assets.

Snowflake

Share Price & News

How has RHT Health Trust's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.6%

RF1U

0.2%

SG Healthcare

-0.002%

SG Market


1 Year Return

-97.4%

RF1U

-11.9%

SG Healthcare

0.7%

SG Market

Return vs Industry: RF1U underperformed the SG Healthcare industry which returned -11.9% over the past year.

Return vs Market: RF1U underperformed the SG Market which returned 0.7% over the past year.


Shareholder returns

RF1UIndustryMarket
7 Day5.6%0.2%-0.002%
30 Day5.6%-0.9%-1.4%
90 Day0%-4.8%-7.3%
1 Year1713.0%-97.4%-10.4%-11.9%4.7%0.7%
3 Year1632.0%-97.8%-19.6%-24.5%15.1%2.8%
5 Year2186.4%-98.1%-14.7%-23.6%10.1%-8.2%

Price Volatility Vs. Market

How volatile is RHT Health Trust's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is RHT Health Trust undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: RF1U (SGD0.02) is trading below our estimate of fair value (SGD0.43)

Significantly Undervalued: RF1U is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: RF1U is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: RF1U is unprofitable, so we can't compare its PE Ratio to the SG market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate RF1U's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: RF1U is good value based on its PB Ratio (0.9x) compared to the SG Healthcare industry average (2.3x).

Future Growth

How is RHT Health Trust forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RHT Health Trust has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has RHT Health Trust performed over the past 5 years?

-53.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: RF1U is unprofitable, and losses have increased over the past 5 years at a rate of -53.2% per year.

Accelerating Growth: Unable to compare RF1U's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RF1U is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-13.3%).


Return on Equity

High ROE: RF1U has a negative Return on Equity (-154.6%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: RF1U is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: RF1U is currently unprofitable, so its Return on Capital Employed is negative.

Financial Health

How is RHT Health Trust's financial position?


Financial Position Analysis

Short Term Liabilities: RF1U's short term assets (SGD18.4M) exceeds its short term liabilities (SGD1.2M)

Long Term Liabilities: RF1U has no long term liabilities


Debt to Equity History and Analysis

Debt Level: RF1U is debt free.

Reducing Debt: RF1U has no debt compared to 5 years ago when its debt to equity ratio was 18.4%.

Debt Coverage: RF1U has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: RF1U has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: RF1U has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if RF1U's debt is covered by short term assets.

Dividend

What is RHT Health Trust's current dividend yield, its reliability and sustainability?

226.32%

Current Dividend Yield


Dividend Yield vs Market

company226.3%marketbottom25%2.6%markettop25%5.7%industryaverage2.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: RF1U's dividend (226.32%) is higher than the bottom 25% of dividend payers in the SG market (2.55%).

High Dividend: RF1U's dividend (226.32%) is in the top 25% of dividend payers in the SG market (5.71%)

Stable Dividend: RF1U has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: RF1U has only been paying a dividend for 6 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: RF1U is paying a dividend but the company is unprofitable.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.

Management

What is the CEO of RHT Health Trust's salary, the management and board of directors tenure and is there insider trading?

1.2yrs

Average management tenure


CEO

Paul Hoahing (50yo)

0.5yrs

Tenure

0

Mr. Paul Hoahing has been Chief Executive Officer of RHT Health Trust Manager Pte. Ltd., since April 1, 2019. Mr. Hoahing has been engaged as a consultant for the treasury and finance functions at Parkway  ...


Management Age and Tenure

1.2yrs

Average Tenure

50yo

Average Age

Experienced Management: RF1U's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Age and Tenure

0.7yrs

Average Tenure

54.5yo

Average Age

Experienced Board: RF1U's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellS$1,188,95321 Feb 19
Mahesh Buxani
EntityIndividual
Shares32,000,000
Max PriceS$0.037
SellS$2,166,48119 Feb 19
Mahesh Buxani
EntityIndividual
Shares56,939,900
Max PriceS$0.038
BuyS$144,99930 Jan 19
Mahesh Buxani
EntityIndividual
Shares5,000,000
Max PriceS$0.029
BuyS$745,72429 Jan 19
Mahesh Buxani
EntityIndividual
Shares29,828,965
Max PriceS$0.025
SellS$12,758,03328 Jan 19
Kabouter Management L.L.C.
EntityCompany
Shares16,782,980
Max PriceS$0.76
BuyS$278,77628 Jan 19
Mahesh Buxani
EntityIndividual
Shares11,151,600
Max PriceS$0.025
SellS$7,846,76825 Jan 19
Kabouter Management L.L.C.
EntityCompany
Shares10,297,612
Max PriceS$0.76
SellS$10,216,13425 Jan 19
Kabouter Management L.L.C.
EntityCompany
Shares13,410,920
Max PriceS$0.76
BuyS$3,799,99425 Jan 19
Mahesh Buxani
EntityIndividual
Shares5,000,000
Max PriceS$0.76
BuyS$4,187,59922 Jan 19
Mahesh Buxani
EntityIndividual
Shares5,490,500
Max PriceS$0.76
BuyS$2,230,89626 Nov 18
Mahesh Buxani
EntityIndividual
Shares3,077,100
Max PriceS$0.72

Ownership Breakdown


Management Team

  • Abdul Jabbar Bin Karam Din

    Joint Company Secretary

    • Tenure: 0yrs
  • KF Tan Tan (57yo)

    Chief Financial Officer

    • Tenure: 0.4yrs
  • Shalini Tyagi

    Deputy GM & Head of Human Resources - India

    • Tenure: 0yrs
  • Mohammad Imtiaz

    Head of Operations & Compliance - India

    • Tenure: 0yrs
  • Vishesh Verma

    Vice President of Investments & Projects - India

    • Tenure: 0yrs
  • Ramnik Ahuja (48yo)

    Vice President of Research & Strategy for Religare Health Trust Trustee Manager Pte. Ltd.

    • Tenure: 4.5yrs
  • Alex Wei

    Executive Officer

    • Tenure: 0yrs
  • Siddhant Jain

    Head of Accounts & Finance - India Operations

    • Tenure: 1.8yrs
  • Fazilah Rahman

    Company Secretary

    • Tenure: 1.2yrs
  • Paul Hoahing (50yo)

    Chief Executive Officer

    • Tenure: 0.5yrs

Board Members

  • Chiang Yin Wong (51yo)

    Independent Director of RHT Health Trust Manager Pte. Ltd.

    • Tenure: 0.7yrs
  • Ronnie Tan (65yo)

    Independent Director of RHT Health Trust Manager Pte. Ltd.

    • Tenure: 0.7yrs
  • Ashish Bhatia (57yo)

    Non Executive Non Independent Director of RHT Health Trust Manager Pte. Ltd.

    • Tenure: 0.4yrs
  • Bong Lin Tan (62yo)

    Non-Executive Chairman of RHT Health Trust Manager Pte. Ltd.

    • Tenure: 0.7yrs
  • Boon Kheng Chan (51yo)

    Non-Executive & Non-Independent Director of RHT Health Trust Manager Pte. Ltd.

    • Tenure: 0.9yrs
  • Min-Jiann Loh (52yo)

    Alternate Director

    • Tenure: 0.4yrs

Company Information

RHT Health Trust's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: RHT Health Trust
  • Ticker: RF1U
  • Exchange: SGX
  • Founded: 2011
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: S$15.417m
  • Shares outstanding: 811.40m
  • Website: https://www.rhealthtrust.com

Location

  • RHT Health Trust
  • No. 09-03/04, Tong Building
  • 302 Orchard Road
  • Singapore
  • 238862
  • Singapore

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RF1USGX (Singapore Exchange)YesCommon UnitsSGSGDOct 2012
RLGH.FOTCPK (Pink Sheets LLC)YesCommon UnitsUSUSDOct 2012

Biography

RHT is the first business trust to be listed on the Main Board of the Singapore Exchange Limited ("SGX-ST") with India based healthcare assets. Since listing, the investment mandate of RHT has been to prin ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/20 13:00
End of Day Share Price2019/10/17 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.